Werewolf Therapeutics (HOWL) Return on Sales (2022 - 2026)
Werewolf Therapeutics (HOWL) posted quarterly Return on Sales of 0.0% for Q2 2026, up 4802.0% year-over-year from 0.0% in Q2 2025, and up 100.01% on a QoQ basis from 48.42% in Q3 2025.
Werewolf Therapeutics (HOWL) Return on Sales (2022 - 2026) Analysis & Trends
Werewolf Therapeutics has reported Return on Sales for 5 years, with the latest figure at 0.0% in Q2 2026.
- Return on Sales for Q2 2026 came in at 0.0%, up 4802.0% year-over-year; the trailing twelve-month figure through Jun 2026 was 0.02% (up 4800.0% YoY), and the FY2024 annual result was 0.71%, down 67.0% from the prior year.
- Return on Sales rose to 0.0% in Q2 2026, from 48.42% in the prior quarter.
- Over five years, Return on Sales peaked at 0.0% in Q2 2026 and troughed at 48.42% in Q3 2025.
- A 5-year average of 7.37% and a median of 0.08% in 2023 frame the typical range for Return on Sales.
- The widest annual swing landed in 2025, when Return on Sales tumbled 4823 bps; it then soared 4802 bps in 2026.
- A 5-year view of Return on Sales shows it stood at 0.02% in 2022, then slumped by 385 bps to 0.08% in 2023, then tumbled by 15755 bps to 12.67% in 2024, then tumbled by 282 bps to 48.42% in 2025, then jumped by 100 bps to 0.0% in 2026.
- Per Business Quant data, the three most recent Return on Sales figures were 0.0% in Q2 2026, 48.42% in Q3 2025, and 48.02% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 0.00% |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -0.05% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.00% |
| 10 | Werewolf Therapeutics | 43.94 Mn | 43.94 Mn | - | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.00% |
| Sep 30, 2025 | -48.42% |
| Jun 30, 2025 | -48.02% |
| Mar 31, 2025 | -0.64% |
| Dec 31, 2024 | -0.38% |
| Sep 30, 2024 | -0.19% |
| Jun 30, 2024 | -0.16% |
| Mar 31, 2024 | -0.22% |
| Dec 31, 2023 | -0.08% |
| Sep 30, 2023 | -0.01% |
| Jun 30, 2023 | -0.01% |
| Mar 31, 2023 | -0.02% |
| Dec 31, 2022 | -0.02% |
| Sep 30, 2022 | -0.02% |
| Jun 30, 2022 | -0.04% |